| Q47295354 | Cell-Based Drug Delivery and Use of Nano-and Microcarriers for Cell Functionalization. |
| Q34709440 | Cell-mediated drug delivery. |
| Q35878143 | Complement activation and cell uptake responses toward polymer-functionalized protein nanocapsules |
| Q42912187 | Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover |
| Q49166049 | Complement activation turnover on surfaces of nanoparticles. |
| Q42723786 | Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo |
| Q26345204 | Current understanding of interactions between nanoparticles and the immune system |
| Q38089879 | Designing PEGylated therapeutic molecules: advantages in ADMET properties |
| Q33985140 | Drug transport to brain with targeted nanoparticles |
| Q37360660 | Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration |
| Q37550733 | Enhanced passive pulmonary targeting and retention of PEGylated rigid microparticles in rats |
| Q37445335 | Heterogeneity in nanoparticles influences biodistribution and targeting |
| Q33525333 | In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles |
| Q30366990 | Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. |
| Q37712288 | Loading of hydrophobic materials into polymer particles: implications for fluorescent nanosensors and drug delivery |
| Q33631069 | Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. |
| Q44394289 | Modulation of lymphatic distribution of subcutaneously injected poloxamer 407-coated nanospheres: the effect of the ethylene oxide chain configuration |
| Q37890639 | Nanomedicine: novel approaches in human and veterinary therapeutics |
| Q37015442 | Nanotechnology: a focus on nanoparticles as a drug delivery system |
| Q39577084 | Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery |
| Q38767557 | PEGylated Cationic Serum Albumin for Boosting Retroviral Gene Transfer |
| Q36604526 | Pharmacokinetic consequences of pegylation |
| Q38047267 | Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking |
| Q28384922 | Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers |
| Q34312572 | Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies |
| Q35893655 | Preparation, characterization, and in vitro drug release behavior of glutathione-sensitive long-circulation micelles based on polyethylene glycol prodrug |
| Q28391811 | Rapid Hepatobiliary Excretion of Micelle-Encapsulated/Radiolabeled Upconverting Nanoparticles as an Integrated Form |
| Q31149542 | Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908. |
| Q38959097 | Recent trends in targeted therapy of cancer using graphene oxide-modified multifunctional nanomedicines |
| Q37883126 | Stabilization and functionalization of iron oxide nanoparticles for biomedical applications |
| Q27496024 | Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers |
| Q35559623 | Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties |
| Q37234835 | Surface Modification of Protein Nanocontainers and Their Self-Directing Character in Polymer Blends |
| Q37978315 | Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy |
| Q41829461 | Third generation gold nanoplatform optimized for radiation therapy |
| Q34704754 | Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat. |